D L ROGERS & SONS LIMITED

Financial Health Assessment: D L Rogers & Sons Limited

1. Financial Health Score: B-

While the patient possesses a robust skeletal structure and strong historical vitality, it is currently suffering from a severe, acute circulatory condition. The company is asset-rich but cash-poor, presenting a dangerous liquidity situation that requires immediate intervention.

2. Key Vital Signs

• Blood Pressure (Liquidity & Cash Flow): Dangerously Low. The company’s cash reserves have flatlined to a mere £646 (down from £676,482 in 2018). For a business of this scale, having virtually no cash in the bank is the financial equivalent of hypovolemic shock.
• Heart Rate (Debtor Collection): Elevated and Strained. Debtors have ballooned to £2.57 million (up from £2.11 million in 2024). The business is pumping out effort and revenue, but the blood isn't returning to the heart quickly enough.
• Muscle Mass (Total Assets): Strong. Total assets have grown to £7.29 million. The business has substantial physical strength, heavily anchored in tangible assets (£3.05M) and investment property (£1.64M).
• Bone Density (Net Worth): Excellent. Net assets stand at a healthy £3.72 million, showing a steady accumulation of wealth over the years (up from £1.92 million in 2016). The structural foundation of the business is very solid.
• Cholesterol (Short-term Liabilities): Rising. Creditors due within one year have increased to £1.57 million (up from £1.27 million). The company appears to be stretching its supplier payments to conserve what little cash it has.

3. Diagnosis

Diagnosis: Financial Anemia with Arterial Blockage (Asset-Rich, Cash-Poor)

D L Rogers & Sons is suffering from a classic case of financial anemia. While the balance sheet shows a healthy, wealthy business on paper (over £3.7 million in shareholder equity), the underlying symptoms reveal a critical lack of working capital circulation.

The primary ailment is a severe arterial blockage in the debtors' cycle. The company is doing the work—operating in the road freight industry—but it is not collecting the cash from its customers promptly. As cash drained from the business over the last several years, the company has had to rely on stretching its own supplier payments (increasing current liabilities) just to keep the lights on.

The good news is that the patient is not terminally ill. The underlying "bone density" (equity) is exceptional, and the company owns significant property and tangible assets. However, a business cannot survive on assets alone; cash is the oxygen that keeps the organs functioning. If a major unexpected expense or a debtor default were to occur right now, the company has virtually no cash reserves to survive the shock.

4. Recommendations

To restore the patient to full health, the following immediate and long-term treatments are prescribed:

1. Emergency Thrombectomy (Improve Debt Collection): This is the most critical intervention. The company must urgently review its credit control procedures. Chase outstanding invoices aggressively, tighten payment terms for customers, and consider offering early payment discounts to accelerate cash inflow.
2. Blood Transfusion (Short-term Financing): Given the strong asset base and property holdings, the company is in an excellent position to secure a working capital facility. An overdraft or invoice financing facility would act as an immediate blood transfusion, providing the necessary cash to operate while debtor collection is improved.
3. Dietary Adjustment (Cash Flow Forecasting): Implement rigorous weekly cash flow forecasting. The business must know exactly when cash is coming in and going out to avoid any payment defaults to critical suppliers or HMRC.
4. Review of Provisions: The balance sheet shows £784,292 in provisions. Management should review these to see if any can be released back into retained earnings, though this should only be done if the underlying liabilities are genuinely no longer required.